Table 2.
Number of Purkinje cells/millimeter in the mice selected for the quantitative analysis
Wild type | Transgenic | ||||
---|---|---|---|---|---|
WT1 | Intact | 50.6 | T1 | Intact | 53.2 |
WT2 | Intact | 49.5 | T2 | Intact | 51 |
WT3 | Intact | 48.7 | T3 | Intact | 49.8 |
WA1 | Axotomy | 37.6 | TA1 | Axotomy | 25.6 |
WA2 | Axotomy | 35.8 | TA2 | Axotomy | 30.3 |
WA3 | Axotomy | 41.7 | TA3 | Axotomy | 20 |
TA4 | Axotomy | 27 | |||
TA5 | Axotomy | 29.9 | |||
WG1 | Graft (cerebellum) | 40.3 | TG1 | Graft (Schwann) | 37.5 |
WG2 | Graft (cerebellum) | 36.5 | TG2 | Graft (cerebellum) | 35.6 |
WG3 | Graft (Schwann) | 36.7 | TG3 | Graft (Schwann) | 38.1 |
For each examined wild-type and transgenic animal (indicated by the acronym on the left of each column) is reported the applied treatment (center of each column; the type of transplant is given in parentheses for the relevant cases) and the number of Purkinje cells/millimeter of Purkinje cell layer length. Data from the different groups have been pooled to produce the histogram of Figure7B.